FDA Moves Toward More Women in Research Trials
The Food and Drug Administration (FDA) recently issued guidelines suggesting that more women, as well as greater racial, ethnic and age diversity, be included in research trials by companies submitting drug and device applications for review and approval. Unfortunately, the agency stopped short of requiring that companies have greater diversity in their study populations and to study the drug’s effects in those sub-populations.